These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32021163)

  • 21. Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates.
    Gansow OA
    Int J Rad Appl Instrum B; 1991; 18(4):369-81. PubMed ID: 1864725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.
    Ray S; Cheng CA; Chen W; Li Z; Zink JI; Lin YY
    Nanotheranostics; 2019; 3(2):166-178. PubMed ID: 31183312
    [No Abstract]   [Full Text] [Related]  

  • 24. Methods for Radiolabeling Nanoparticles (Part 3): Therapeutic Use.
    Bentivoglio V; Nayak P; Varani M; Lauri C; Signore A
    Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands.
    Hens M; Vaidyanathan G; Welsh P; Zalutsky MR
    Nucl Med Biol; 2009 Feb; 36(2):117-28. PubMed ID: 19217523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
    Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
    J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and acyclic ligands.
    Stimmel JB; Kull FC
    Nucl Med Biol; 1998 Feb; 25(2):117-25. PubMed ID: 9468026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of quenchers to reduce radiolysis of (111)In- or (177)Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC.
    de Blois E; Chan HS; Konijnenberg M; de Zanger R; Breeman WA
    Curr Top Med Chem; 2012; 12(23):2677-85. PubMed ID: 23339763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and characterization of lutetium-177-labeled stannous (tin) colloid for radiosynovectomy.
    Arora G; Singh M; Jha P; Tripathy S; Bal C; Mukherjee A; Shamim SA
    Nucl Med Commun; 2017 Jul; 38(7):587-592. PubMed ID: 28538080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absolute peptide quantification by lutetium labeling and nanoHPLC-ICPMS with isotope dilution analysis.
    Rappel C; Schaumlöffel D
    Anal Chem; 2009 Jan; 81(1):385-93. PubMed ID: 19117464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HNODThia: A Promising Chelator for the Development of
    Hierlmeier I; Guillou A; Earley DF; Linden A; Holland JP; Bartholomä MD
    Inorg Chem; 2023 Dec; 62(50):20677-20687. PubMed ID: 37487036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for
    Pandey U; Gamre N; Lohar SP; Dash A
    Appl Radiat Isot; 2017 Sep; 127():1-6. PubMed ID: 28478331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labelling of
    Iori M; Capponi PC; Rubagotti S; Esposizione LR; Seemann J; Pitzschler R; Dreger T; Formisano D; Grassi E; Fioroni F; Versari A; Asti M
    Contrast Media Mol Imaging; 2017; 2017():8160134. PubMed ID: 29097938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and Evaluation of
    Ghosh S; Das T; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2017 Sep; 32(7):239-246. PubMed ID: 28876087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice.
    Jin ZH; Furukawa T; Ohya T; Degardin M; Sugyo A; Tsuji AB; Fujibayashi Y; Zhang MR; Higashi T; Boturyn D; Dumy P; Saga T
    Nucl Med Commun; 2017 Apr; 38(4):347-355. PubMed ID: 28291159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3p-C-NETA: A versatile and effective chelator for development of Al
    Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
    Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
    [No Abstract]   [Full Text] [Related]  

  • 38. Dual Radionuclide Theranostic Pretargeting.
    Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
    Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid chelator-free radiolabeling of quantum dots for in vivo imaging.
    Tang T; Wei Y; Yang Q; Yang Y; Sailor MJ; Pang HB
    Nanoscale; 2019 Nov; 11(46):22248-22254. PubMed ID: 31746913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
    Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.